IFNG and hepatocellular carcinoma: The percentage of IFNγ+ T cells in peripheral blood is downregulated persistently during the tumor growth progressively among the B16-F10 pulmonary metastatic and H22 intraperitoneal hepatoma models, while in the BMSC-treated mice groups the percentages of IFNγ+ T cells were elevated about 15% (Figure 4).